德英生物科技
詢價車

Important Resolutions of the Board of Directors in 2024

Important Resolutions of the Board of Directors in 2024

▌Tip: The table can be scrolled horizontally
Date Agenda Item Resolution
2024.03.08 Item 1: Proposal for the allocation of employee and director compensation for the fiscal year 2023, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors and will be reported to the Shareholders’ Meeting.
Item 2: Financial statements for the fiscal year 2023, submitted for review. The proposal was approved as submitted after the Chairman consulted all attending directors, and after review and audit by PricewaterhouseCoopers accountants Hsu Hui-Yu and Yeh Fang-Ting, it will be submitted to the Shareholders’ Meeting for approval.
Item 3: Business report for the fiscal year 2023, submitted for review. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 4: Proposal for profit distribution for the fiscal year 2023, submitted for review. The proposal was approved as submitted after the Chairman consulted all attending directors and will be submitted to the Shareholders’ Meeting for approval.
Item 5: Proposal for capital increase through earnings capitalization, submitted for review. The proposal was approved as submitted after the Chairman consulted all attending directors and will be submitted to the Shareholders’ Meeting for discussion.
Item 6: Internal control self-assessment for the fiscal year 2023 completed, with proposal to issue an internal control statement. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 7: Proposal on evaluation of the suitability of the company’s accountants, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 8: Proposal on the independence assessment of the certified public accountants, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 9: Proposal to appoint Hsu Hui-Yu and Yeh Fang-Ting of PricewaterhouseCoopers as auditors for the fiscal year 2024 financial statements, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 10: Proposal to amend the "Rules of Procedure for Board of Directors Meetings," submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors and will be reported to the Shareholders’ Meeting.
Item 11: Proposal to set matters related to the 2024 Annual Shareholders’ Meeting, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
2024.05.03 Item 1: Financial statements for Q1 2024, submitted for review. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 2: Proposal to entrust PricewaterhouseCoopers to handle the 2024 financial statements audit, corporate income tax verification, and full-time salary information of non-executive staff, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 3: Renewal of Directors’ Liability Insurance for 2024, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
2024.08.02 Item 1: Financial statements for Q2 2024, submitted for review. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 2: Proposal for capital increase through earnings capitalization for 2023 and setting the ex-rights date, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 3: Proposal to set the ex-dividend date and dividend payment date for cash dividends from 2023 earnings, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 4: Proposal to outsource the "Interior Renovation of Southern Taiwan Science Park Cosmetics Factory," submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
2024.11.01 Item 1: Financial statements for Q3 2024, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 2: Proposal to establish the “Sustainable Information Management Procedure” under the company’s internal control system, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 3: Review of the appointment of the company’s "Internal Audit Supervisor," submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
2024.12.13 Item 1: Proposal for the 2025 company budget, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 2: Proposal for the 2025 internal audit plan, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 3: Proposal to amend the internal control system’s rules for "appointment, evaluation, and compensation of internal audit personnel," submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 4: Review of the appointment of the company’s "Internal Audit Supervisor," submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 5: Review of the appointment of the company’s "Corporate Governance Supervisor," submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors.
Item 6: Proposal for distribution of semi-annual performance bonuses for employees (including managers) for 2024, submitted for discussion. The proposal was approved as submitted after the Chairman consulted all attending directors, authorizing the General Manager to allocate bonuses based on individual employee performance and contribution.